STARR KEVIN P 4
4 · Sage Therapeutics, Inc. · Filed Jun 17, 2021
Insider Transaction Report
Form 4
STARR KEVIN P
Director10% Owner
Transactions
- Purchase
Common Stock
2021-06-16$56.05/sh+17,842$999,983→ 320,659 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $56.0447 USD to $56.9527 USD. The price reported above reflects the weighted average purchase price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.